HomeNews

News

High FDA Approvals of Oncology Therapies in 2024

A glance again on the FDA's prime approvals of oncology therapies in 2024.All through 2024, the Meals and Drug Administration (FDA) permitted many...

Epkinly Results in Responses in Closely Pretreated Sufferers With CLL

Epkinly monotherapy demonstrated deep responses and a positive security profile in sufferers with closely pretreated persistent lymphocytic leukemia.Closely pretreated sufferers with persistent lymphocytic...

Recognizing Excellence in Oncology Nursing

In the course of the COVID-19 pandemic, Sharon continued to embrace her calmness to supply care and help. I'm honored to appoint Sharon...

FDA Grants Jemperli Breakthrough Remedy Designation in dMMR/MSI-H Rectal Most cancers

The FDA just lately granted a breakthrough remedy designation to Jemperli for sure sufferers with rectal most cancers. Remedy with Jemperli (dostarlimab-gxly) has...

Darzalex Routine Might Enhance MRD Responses in A number of Myeloma

A therapy mixture referred to as D-VRd confirmed enhancements in minimal-residual illness responses in sure sufferers with newly identified a number of myeloma....

Hot Topics